StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 3/30
$4.15−0.02 (-0.48%)

Close on Nov 19, 2026Market cap $33.46MP/E –Yield –

Cryo-Cell International free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cryo-Cell International's free cash flow for the twelve months ending Aug 31, 2026 was $4.65M, down 24.8% year over year. For fiscal 2025 it was $5.25M, up 45.5% from the year before. Over ten years it grew 1.0% a year on average. The highest annual figure on record is $8.37M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Nov 30, 2025$5.25M+45.5%
FY2024Nov 30, 2024$3.61M+73.4%
FY2023Nov 30, 2023$2.08M–
FY2022Nov 30, 2022-$3.60M-159.0%
FY2021Nov 30, 2021$6.09M-27.2%
FY2020Nov 30, 2020$8.37M+48.5%
FY2019Nov 30, 2019$5.63M+15.3%
FY2018Nov 30, 2018$4.89M-13.0%
FY2017Nov 30, 2017$5.62M+21.0%
FY2016Nov 30, 2016$4.64M-2.1%
FY2015Nov 30, 2015$4.74M+230.7%
FY2014Nov 30, 2014$1.43M+203.8%
FY2013Nov 30, 2013$472.20K+107.7%
FY2012Nov 30, 2012$227.36K-27.5%
FY2011Nov 30, 2011$313.41K-83.8%
FY2010Nov 30, 2010$1.94M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Aug 31, 2026$1.04M-58.4%
Q2 FY2026CQ2 2026May 31, 2026$1.81M+181.3%
Q1 FY2026CQ1 2026Feb 28, 2026$584.76K-34.4%
Q4 FY2025CQ4 2025Nov 30, 2025$1.21M-43.5%
Q3 FY2025CQ3 2025Aug 31, 2025$2.50M+10.9%
Q2 FY2025CQ2 2025May 31, 2025$644.61K+2891.3%
Q1 FY2025CQ1 2025Feb 28, 2025$892.01K–
Q4 FY2024CQ4 2024Nov 30, 2024$2.15M+31.9%
Q3 FY2024CQ3 2024Aug 31, 2024$2.25M–
Q2 FY2024CQ2 2024May 31, 2024$21.55K-95.9%
Q1 FY2024CQ1 2024Feb 29, 2024-$814.59K-164.2%
Q4 FY2023CQ4 2023Nov 30, 2023$1.63M-33.6%
Q3 FY2023CQ3 2023Aug 31, 2023-$1.35M–
Q2 FY2023CQ2 2023May 31, 2023$531.66K-67.6%
Q1 FY2023CQ1 2023Feb 28, 2023$1.27M+47.6%
Q4 FY2022CQ4 2022Nov 30, 2022$2.45M+76.9%
Q3 FY2022CQ3 2022Aug 31, 2022-$8.55M-1720.1%
Q2 FY2022CQ2 2022May 31, 2022$1.64M+7.4%
Q1 FY2022CQ1 2022Feb 28, 2022$859.12K-67.6%
Q4 FY2021CQ4 2021Nov 30, 2021$1.39M-52.6%
Q3 FY2021CQ3 2021Aug 31, 2021$527.74K-74.3%
Q2 FY2021CQ2 2021May 31, 2021$1.53M+96.0%
Q1 FY2021CQ1 2021Feb 28, 2021$2.65M+1.6%
Q4 FY2020CQ4 2020Nov 30, 2020$2.93M+202.1%
Q3 FY2020CQ3 2020Aug 31, 2020$2.05M-23.8%
Q2 FY2020CQ2 2020May 31, 2020$778.93K+363.9%
Q1 FY2020CQ1 2020Feb 29, 2020$2.61M+44.5%
Q4 FY2019CQ4 2019Nov 30, 2019$969.50K+20.3%
Q3 FY2019CQ3 2019Aug 31, 2019$2.69M+3.0%
Q2 FY2019CQ2 2019May 31, 2019$167.90K+424.1%
Q1 FY2019CQ1 2019Feb 28, 2019$1.80M+25.5%
Q4 FY2018CQ4 2018Nov 30, 2018$806.12K-61.0%
Q3 FY2018CQ3 2018Aug 31, 2018$2.61M+122.5%
Q2 FY2018CQ2 2018May 31, 2018$32.03K-98.4%
Q1 FY2018CQ1 2018Feb 28, 2018$1.44M+237.5%
Q4 FY2017CQ4 2017Nov 30, 2017$2.07M-17.9%
Q3 FY2017CQ3 2017Aug 31, 2017$1.17M–
Q2 FY2017CQ2 2017May 31, 2017$1.95M–
Q1 FY2017CQ1 2017Feb 28, 2017$426.14K–
Q4 FY2016CQ4 2016Nov 30, 2016$2.52M–

More Cryo-Cell International figures

See a number that looks wrong?